Evaluation of the results of two different pancreatic transplant surgery techniques in the treatment of type 1 diabetic patients

Evaluation of the outcomes and complications of use of extended carotid artery with Y-graft technique versus conventional Y-graft technique in pancreatic transplant surgery in the treatment of type 1 diabetic patients; A prospective randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210625051701N2

Enrollment

Registered

2022-05-12

Start date

2022-06-01

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: ????? ??? 1. Condition 2: Pancreas transplant. Type 1 diabetes mellitus Pancreas transplant status

Interventions

Intervention 1: Intervention group: Laparotomy will be performed first and then portal vein drainage will be done. In case of difficulty in exploration and exposing SMV, anastomosis to IVC will be per

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient's consent Pancreas transplant form (living donor or deceased donor) Having a simultaneous pancreas-kidney (SPK) transplant Patients with diabetic nephropathy who undergo portal venous drainage

Exclusion criteria

Exclusion criteria: Unwillingness to participate in study Patients who undergo systemic venous drainage Patients who undergo pancreas transplant alone (PTA)

Design outcomes

Primary

Measure	Time frame
Transplant rejection. Timepoint: Up to 28 days after surgery. Method of measurement: Clinical features and diagnostic tests.;Incidence of arterial complications. Timepoint: Up to 28 days after surgery. Method of measurement: Sonography.;Mortality. Timepoint: Up to 28 days after surgery. Method of measurement: Absence of pulse rate and flat ECG.	—

Secondary

Measure	Time frame
Operation time. Timepoint: During operation. Method of measurement: Using the timer.;Incidence of postoperative pancreatitis. Timepoint: Up to 28 days after surgery. Method of measurement: Lab data and Sonography.;The cold ischemic phase. Timepoint: From 24 hours before surgery. Method of measurement: Using the timer.;The warm ischemic time. Timepoint: From the time the donor organ is removed from the storage ice to the start of re-perfusion after transplantation. Method of measurement: Using the timer.	—

Measure

Time frame

Operation time. Timepoint: During operation. Method of measurement: Using the timer.;Incidence of postoperative pancreatitis. Timepoint: Up to 28 days after surgery. Method of measurement: Lab data and Sonography.;The cold ischemic phase. Timepoint: From 24 hours before surgery. Method of measurement: Using the timer.;The warm ischemic time. Timepoint: From the time the donor organ is removed from the storage ice to the start of re-perfusion after transplantation. Method of measurement: Using the timer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad mahdi Mahmoudi

Shiraz University of Medical Sciences

Mm.mahmoudi70@gmail.com+98 21 2246 5035

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026